E. Marcus

发表

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer

A. Robidoux, E. Bareke, N. Alirezaie, 2020, Scientific Reports.

Process improvement in breast cancer care: Is mammography volume associated with a greater need for process improvement?

D. Ansell, J. Trosman, C. Weldon, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A community effort to reduce the black/white breast cancer mortality disparity in Chicago

C. Ferrans, D. Ansell, R. Rao, 2009, Cancer Causes & Control.

Clinical outcome correlation of positron emission tomography (PET) in patients with locally advanced breast cancer (LABC) treated with neoadjuvant doxorubicin and docetaxel

J. Coon, Atif J. Khan, A. Dickler, 2003 .

Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma.

Paul R. Avery, J. Eickhoff, P. Morley, 2011, Journal of veterinary internal medicine.

Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer.

H. Preisler, J. Coon, S. Seelig, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

P. Tonellato, C. Borchers, A. Robidoux, 2019, Molecular Cancer Research.

The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience

G. Batist, A. Robidoux, M. Basik, 2017, Modern Pathology.

Predicting response to neoadjuvant chemotherapy in nonmetastatic hormone receptor-positive breast cancer using 21-gene Breast Recurrence Score test.

T. Lad, M. Sekosan, E. Marcus, 2019, Journal of Clinical Oncology.

Assessing the Impact of CALGB 9343 on Surgical Trends in Elderly-Women With Stage I ER+ Breast Cancer: A SEER-Based Analysis

J. White, J. Bazan, J. Fisher, 2019, Front. Oncol..

Breast cancer screening, diagnosis, and treatment.

E. Marcus, K. Ford, B. Lum, 1999, Disease-a-month : DM.

Papillary lesions of the breast discovered on percutaneous large core and vacuum-assisted biopsies: reliability of clinical and pathological parameters in identifying benign lesions.

H. Zaren, I. Ashkenazi, R. Lavy, 2007, American journal of surgery.

Locally Advanced Breast Cancer

E. Marcus, 2003 .

The management of Paget’s disease of the breast

E. Marcus, 2004, Current treatment options in oncology.

Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma.

J. Eickhoff, P. Morley, A. Avery, 2011, Journal of veterinary internal medicine.

Circulating tumor DNA (ctDNA) during and after neoadjuvant chemotherapy and prior to surgery is a powerful prognostic factor in triple-negative breast cancer (TNBC).

A. Robidoux, E. Bareke, N. Alirezaie, 2019, Journal of Clinical Oncology.

Prognostic factors affecting survival in patients with colorectal carcinomatosis.

N. Petrelli, D. Driscoll, T. Weber, 1999, Cancer investigation.